PSYGF Stock Price, Chart, Stats & News

Psyence Group Inc. is a biotechnology firm operating in the life sciences sector, primarily focused on the commercial cultivation and production of psilocybin mushrooms. The company's naturally derived psilocybin is intended for therapeutic applications, targeting a variety of mental health conditions and other medical ailments. Currently, Psyence Group Inc. is engaged in formulating pharmaceutical-grade psilocybin dosages aimed at alleviating psychological trauma and specific diagnosable disorders, such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress associated with grief and bereavement.